S100A4 and Peritoneal Fibrosis: In this study, we demonstrated that linagliptin suppressed the expression of fibrotic markers, such as α-SMA, fibroblast-specific protein-1 (FSP-1), and type I and III collagen, and inhibited macrophage infiltration in a mouse model of MGO-induced peritoneal fibrosis.